RSCI Stock Overview
Redwood Scientific Technologies, Inc. develops and markets over-the-counter FDA registered drugs through oral strip delivery technology.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Redwood Scientific Technologies, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$1.24 |
52 Week High | US$1.64 |
52 Week Low | US$0.072 |
Beta | 0 |
1 Month Change | 37.78% |
3 Month Change | 1,016.11% |
1 Year Change | 1,610.34% |
3 Year Change | 2,162.77% |
5 Year Change | 5,804.76% |
Change since IPO | -99.99% |
Recent News & Updates
Recent updates
Shareholder Returns
RSCI | US Personal Products | US Market | |
---|---|---|---|
7D | 22.8% | -0.8% | 0.6% |
1Y | 1,610.3% | -26.5% | 29.5% |
Return vs Industry: RSCI exceeded the US Personal Products industry which returned -27.1% over the past year.
Return vs Market: RSCI exceeded the US Market which returned 29.8% over the past year.
Price Volatility
RSCI volatility | |
---|---|
RSCI Average Weekly Movement | 52.1% |
Personal Products Industry Average Movement | 10.0% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.9% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: RSCI's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine RSCI's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | Ben Lefrancois | https://www.redwoodscientific.co |
Redwood Scientific Technologies, Inc. develops and markets over-the-counter FDA registered drugs through oral strip delivery technology. The company is based in Claremont, California.
Redwood Scientific Technologies, Inc. Fundamentals Summary
RSCI fundamental statistics | |
---|---|
Market cap | US$253.18m |
Earnings (TTM) | -US$979.33k |
Revenue (TTM) | US$259.71k |
0.0x
P/S Ratio0.0x
P/E RatioIs RSCI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
RSCI income statement (TTM) | |
---|---|
Revenue | US$259.71k |
Cost of Revenue | US$129.66k |
Gross Profit | US$130.05k |
Other Expenses | US$1.11m |
Earnings | -US$979.33k |
Last Reported Earnings
Mar 31, 2012
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did RSCI perform over the long term?
See historical performance and comparison